Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Licenses Pathway Analysis Software to Genizon BioSciences ...

NEW YORK, Oct. 25 (GenomeWeb News) - Ingenuity Systems will license its pathway analysis software to Genizon BioSciences, the companies announced today.

 

Under the agreement, Genizon will apply Ingenuity Pathways Analysis 3.0 to its lead programs studying Crohn's disease, psoriasis, asthma, baldness, and schizophrenia.

 

Genizon, formerly called Galileo Genomics, conducts whole genome-association studies on common diseases to identify major genes and their interactions.

 

The Ingenuity Pathway Analysis product enables scientists to create and analyze custom networks for targets, biomarkers, disease areas, and processes.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.